Bone Marrow-derived Osteoblasts in the Management of Ovariectomy induced Osteoporosis in Rats.

IF 1.1 Q4 CELL & TISSUE ENGINEERING Journal of Stem Cells & Regenerative Medicine Pub Date : 2018-12-30 eCollection Date: 2018-01-01
Mir Sadat-Ali, Haifa A Al-Turki, Sadananda Acharya, Dakheel A Al-Dakheel
{"title":"Bone Marrow-derived Osteoblasts in the Management of Ovariectomy induced Osteoporosis in Rats.","authors":"Mir Sadat-Ali,&nbsp;Haifa A Al-Turki,&nbsp;Sadananda Acharya,&nbsp;Dakheel A Al-Dakheel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: The objective of this study is to assess if infusion of osteoblasts can temporarily reverse osteoporosis in rats. <b>Methods:</b> Osteoporosis was induced in 20 female Sprague-Dawley rats by performing ovariectomy (OVX) that was carried out at 4 weeks of age. At 3 months a biopsy of the iliac crest was made to assess the bone quality and the same site bone marrow was harvested. From the bone marrow aspirate, MSCs were separated. Osteoblasts were then generated and were characterized using Alizarin red staining. Osteoblasts were injected in the tail vein of 10 rats. Two weeks after the injection of osteoblasts, a second biopsy was done. Animals were euthanized after 8 weeks of osteoblasts infusion by overdose of ketamine mixed with xylazine. The whole femurs and lumbar spine were dissected and the specimens were stored in 2% formalin. The specimens were analyzed using HRpQCT (High-resolution peripheral quantitative computerized tomography (μCT 100, SCANCO Medical AG, Brüttisellen, Switzerland). <b>Results:</b> In all the 10 animals from which bone aspiration was performed, osteoblasts were cultured and transplanted. Analysis showed that there was significant bone formation at bone sites of distal femur and lumbar spine (<0.001), with increased number of trabeculae and thickness (P<0.001). Further analysis revealed that there was robust bone formation in the animals that had osteoblasts injection. <b>Conclusions</b>: This preliminary study indicates that osteoblasts infusion can lead to new bone formation in osteoporosis induced by ovariectomy in rats.</p>","PeriodicalId":17155,"journal":{"name":"Journal of Stem Cells & Regenerative Medicine","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2018-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339979/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Stem Cells & Regenerative Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The objective of this study is to assess if infusion of osteoblasts can temporarily reverse osteoporosis in rats. Methods: Osteoporosis was induced in 20 female Sprague-Dawley rats by performing ovariectomy (OVX) that was carried out at 4 weeks of age. At 3 months a biopsy of the iliac crest was made to assess the bone quality and the same site bone marrow was harvested. From the bone marrow aspirate, MSCs were separated. Osteoblasts were then generated and were characterized using Alizarin red staining. Osteoblasts were injected in the tail vein of 10 rats. Two weeks after the injection of osteoblasts, a second biopsy was done. Animals were euthanized after 8 weeks of osteoblasts infusion by overdose of ketamine mixed with xylazine. The whole femurs and lumbar spine were dissected and the specimens were stored in 2% formalin. The specimens were analyzed using HRpQCT (High-resolution peripheral quantitative computerized tomography (μCT 100, SCANCO Medical AG, Brüttisellen, Switzerland). Results: In all the 10 animals from which bone aspiration was performed, osteoblasts were cultured and transplanted. Analysis showed that there was significant bone formation at bone sites of distal femur and lumbar spine (<0.001), with increased number of trabeculae and thickness (P<0.001). Further analysis revealed that there was robust bone formation in the animals that had osteoblasts injection. Conclusions: This preliminary study indicates that osteoblasts infusion can lead to new bone formation in osteoporosis induced by ovariectomy in rats.

Abstract Image

Abstract Image

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
骨髓源性成骨细胞治疗大鼠卵巢切除所致骨质疏松症。
背景:本研究的目的是评估输注成骨细胞是否能暂时逆转大鼠骨质疏松症。方法:20只雌性Sprague-Dawley大鼠在4周龄时行卵巢切除术(OVX)诱导骨质疏松症。3个月时,对髂骨进行活检以评估骨质量,并采集同一部位的骨髓。从抽吸的骨髓中分离MSCs。然后生成成骨细胞并用茜素红染色对其进行表征。10只大鼠尾静脉注射成骨细胞。注射成骨细胞两周后,进行第二次活检。动物在成骨细胞输注过量氯胺酮与噻嗪混合8周后安乐死。全股骨、腰椎解剖,标本保存在2%福尔马林中。采用HRpQCT(高分辨率外周定量计算机断层扫描(μCT 100, SCANCO Medical AG, br ttisellen,瑞士)对标本进行分析。结果:10只动物均成功培养成骨细胞并移植成骨。结论:本初步研究表明,在大鼠卵巢切除所致骨质疏松症中,输注成骨细胞可导致新骨形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
5
审稿时长
14 weeks
期刊最新文献
Amniotic Fluid Stem Cells and Their Secretomes as tools of regenerative medicine; Influence of Donor Characteristics on Standardization. MSC secretome from amniotic fluid halts IL-1β and TNF-α inflammation via the ERK/MAPK pathway, promoting cartilage regeneration in OA in vitro. The Therapeutic Potential of Human Umbilical Cord Mesenchymal Stromal Cells Derived Exosomes for Wound Healing: Harnessing Exosomes as a Cell-free Therapy. Cues from evolving insights about Cancer stem cells to tackle cancer metastases. I. Biomaterials for reconstruction of bone and cartilage defects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1